# Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

> **NCT00028600** · PHASE2 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 60 (actual)

## Conditions studied

- Multiple Myeloma
- Plasma Cell Neoplasm

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** CD34+ cells
- **DRUG:** cyclophosphamide
- **DRUG:** fludarabine phosphate
- **DRUG:** melphalan
- **DRUG:** methotrexate
- **DRUG:** tacrolimus

## Key facts

- **NCT ID:** NCT00028600
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2006-06
- **Final completion:** 2010-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-07-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00028600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00028600, "Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00028600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*